Inogen (INGN) FCF Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,171.00 |
| Dec 31, 2025 | -2,197.00 |
| Sep 30, 2025 | -153.00 |
| Jun 30, 2025 | -1,868.00 |
| Mar 31, 2025 | -1,963.00 |
| Dec 31, 2024 | -1,582.00 |
| Sep 30, 2024 | -1,004.00 |
| Jun 30, 2024 | -840.00 |
| Mar 31, 2024 | -471.00 |
| Dec 31, 2023 | -453.00 |
| Sep 30, 2023 | -2,150.00 |
| Jun 30, 2023 | -1,433.00 |
| Mar 31, 2023 | -2,168.00 |
| Dec 31, 2022 | -4,456.00 |
| Sep 30, 2022 | -2,955.00 |
| Jun 30, 2022 | -2,377.00 |
| Mar 31, 2022 | -4,666.00 |
| Dec 31, 2021 | -211.00 |
| Sep 30, 2021 | -2,136.00 |
| Jun 30, 2021 | -586.00 |
| Mar 31, 2021 | -584.00 |
| Dec 31, 2020 | -2,927.00 |
| Sep 30, 2020 | -1,935.00 |
| Jun 30, 2020 | 2,156.00 |
| Mar 31, 2020 | -1,745.00 |
| Dec 31, 2019 | -524.00 |
| Sep 30, 2019 | 868.00 |
| Jun 30, 2019 | -1,259.00 |
| Mar 31, 2019 | 329.00 |
| Dec 31, 2018 | -260.00 |
| Sep 30, 2018 | -2,974.00 |
| Jun 30, 2018 | 2,107.00 |
| Mar 31, 2018 | 1,584.00 |